Prevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Case-Control Study

• Gunter Assmann ,

  * E-mail: gunter.assmann@uks.eu

  Affiliation Department of Internal Medicine I, José-Carreras-Centre for Immuno- and Gene Therapy, University Medical School of Saarland, Homburg/Saar, Germany

  ⨯
• Klara Shihadeh,

  Affiliation Department of Internal Medicine, General Hospital of Herrenberg, Esslingen-Herrenberg, Germany

  ⨯
• Viola Poeschel,

  Affiliation Department of Internal Medicine I, José-Carreras-Centre for Immuno- and Gene Therapy, University Medical School of Saarland, Homburg/Saar, Germany

  ⨯
• Niels Murawski,

  Affiliation Department of Internal Medicine I, José-Carreras-Centre for Immuno- and Gene Therapy, University Medical School of Saarland, Homburg/Saar, Germany

  ⨯
• Jutta Conigliarou,

  Affiliation Department of Internal Medicine I, José-Carreras-Centre for Immuno- and Gene Therapy, University Medical School of Saarland, Homburg/Saar, Germany

  ⨯
• Mei Fang Ong,

  Affiliation Institute of Medical Biometry, Epidemiology and Medical Informatics, Saarland University, Homburg/Saar, Germany

  ⨯
• Michael Pfreundschuh

  Affiliation Department of Internal Medicine I, José-Carreras-Centre for Immuno- and Gene Therapy, University Medical School of Saarland, Homburg/Saar, Germany

  ⨯